RIGGS RORY B Insider Trades

Insider Trading History

Track insider trading activity for RIGGS RORY B. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cibus
Cibus CBUS
Director
Holding Value $106k 77,586 shares
Last Trade
Jun 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$108k 77,586 shares
$1.39
$1.37
Cibus
Cibus CBUS
10% owner
Holding Value $20.4M 14,916,640 shares
Last Trade
Jan 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$637k 333,333 shares
$1.91
$1.37
Cibus
Cibus CBUS
10% owner
Holding Value $20M 14,583,307 shares
Last Trade
Jun 09, 2025 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$82.5k 50,000 shares
$1.65
$1.37
Cibus
Cibus CBUS
10% owner
Holding Value $0 0 shares
Last Trade
Jun 09, 2025 Sale (In The Money)Reported as In The Money on SEC Form 4.
$82.5k 50,000 shares
$1.65
$1.37
Cibus
Cibus CBUS
10% owner
Holding Value $14.4M 10,533,307 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.86M 5,714,286 shares
$1.55
$1.37
Cibus
Cibus CBUS
Director
Holding Value $53.8k 39,301 shares
Last Trade
May 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$109k 39,301 shares
$2.77
$1.37
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Director
Holding Value $0 0 shares
Last Trade
Apr 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.64M 20,000 shares
$131.87
$131.87
Cibus
Cibus CBUS
10% owner, Chief Executive Officer
Holding Value $5.48M 4,000,000 shares
Last Trade
Jan 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10M 4,000,000 shares
$2.50
$1.37
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Director
Holding Value $17.3M 131,512 shares
Last Trade
Dec 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18k 215 shares
$83.52
$131.87
Cibus
Cibus CBUS
10% owner, Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Dec 31, 2024 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$3.86M 1,388,084 shares
$2.78
$1.37
Cibus
Cibus CBUS
10% owner, Chief Executive Officer
Holding Value $6.63M 4,839,912 shares
Last Trade
Dec 31, 2024 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$3.86M 1,388,084 shares
$2.78
$1.37
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Director
Holding Value $15.4M 117,108 shares
Last Trade
Sep 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18k 246 shares
$73.17
$131.87
Cibus
Cibus CBUS
10% owner, Chief Executive Officer
Holding Value $4.73M 3,451,828 shares
Last Trade
Sep 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$899k 250,000 shares
$3.60
$1.37
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Director
Holding Value $15.4M 116,862 shares
Last Trade
Jun 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.9k 262 shares
$68.49
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Director
Holding Value $15.4M 116,600 shares
Last Trade
Jun 24, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$337k 4,462 shares
$75.57
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Director
Holding Value $0 0 shares
Last Trade
Jun 24, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.51M 20,000 shares
$75.57
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Director
Holding Value $16M 121,062 shares
Last Trade
Jun 24, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.51M 20,000 shares
$75.57
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Director
Holding Value $0 0 shares
Last Trade
Jun 23, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$120k 1,567 shares
$76.58
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Director
Holding Value $13.3M 101,062 shares
Last Trade
Jun 23, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$120k 1,567 shares
$76.58
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Director
Holding Value $570k 4,322 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$293k 4,322 shares
$67.77
$131.87

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up